The device, called the unidose liquid system, is the first and only nasal treatment for patients with epilepsy. A plunger on the bottom of the device releases a drug into a patients’ nostril, which is quickly absorbed by the nasal mucosa.
The device can be used during or after a seizure and can be administered by people who are not healthcare professionals. Aptar’s subsidiary, Noble International, made a training device to teach caregivers how to use the system.
Read the full article here.
More articles on supply chain:
Walgreens, Kroger form GPO
Abbott warns of 2 potential safety issues with its heart implant
Edwards Lifesciences predicts $5B in revenue in 2020
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.